Ask Orbit
Supply & Distribution
Supply & Distribution/Backorders & Supply Risk

Backorders & Supply Risk

Prioritised view of unfulfilled demand, blocked revenue and recovery actions.

1 – 30 Jun 2026·All Divisions·All Regions·All Products·All Accounts
Demo Data
Measure
Status
Severity
Ageing
View
Orbit Backorder Briefing
Updated 14 min ago

Backorder value has increased to R6.7m, with 62% concentrated in three products. Cardiaxol and Respireze account for the highest blocked revenue, affecting 18 key accounts. R2.1m is ready for partial fulfilment, while the remaining risk is linked to delayed inbound stock.

Total Backorder Value
R6.7m
Rising
+R0.6m vs prev period
Open Backorder Units
184.6k
+6.4k vs prev period
Affected Products
22
+3 vs prev period
Affected Accounts
47
High
+5 vs prev period
Ready to Fulfil
R2.1m
Actionable
+R0.2m vs prev period
Revenue at Critical Risk
R3.8m
Critical
62% in 3 products
Backorders by ageing
Open, ready & allocated units per band
Open
Ready
Allocated
Backorder trend
Value, open units & ready-to-fulfil
Value (Rm)
Ready (Rm)
Priority actions
Orbit-ranked interventions for this period
Critical
Expedite inbound shipment
Cardiaxol 20mg
Risk
R1.6m
Accounts
8
Horizon
Stockout in 9 days
Owner
Supply Planning
Priority
Partially fulfil ready quantity
Respireze Inhaler
Risk
R0.8m
Accounts
6
Horizon
Ready today
Owner
Customer Service
Priority
Reallocate excess stock
Gastraven 20mg
Risk
R0.4m
Accounts
3
Horizon
Transfer 420u A → C
Owner
Distribution
Recovery status
Expected fulfilment timing
Ready nowR2.1m
Within 7 daysR1.8m
Within 14 daysR1.4m
UnconfirmedR1.4m
Root causes
Delayed inbound stock
38%
Demand above forecast
24%
Allocation constraint
18%
Product shortage
12%
Order-processing issue
8%
Highest-impact products
Ranked by blocked revenue
Cardiaxol 20mg
46,000u12 accts18dR2.1m
Respireze Inhaler
34,000u8 accts22dR1.6m
Pulmavent DPI
12,000u6 accts14dR0.9m
Cardiaxol 40mg
9,800u5 accts26dR0.7m
Gastraven 20mg
7,200u4 accts9dR0.5m
Neurospen 500
4,600u3 accts11dR0.3m
Most affected accounts
Ranked by blocked revenue
MediRite Sandton
4 products · oldest 34d
criticalR0.62m
Netcare Pinelands
3 products · oldest 28d
criticalR0.48m
Life Hospital Umhlanga
3 products · oldest 22d
warningR0.41m
Dis-Chem Menlyn
2 products · oldest 18d
warningR0.38m
Clicks Rondebosch
2 products · oldest 16d
warningR0.29m
Regional Hospital Z
2 products · oldest 41d
criticalR0.24m
Risks & opportunities
Prioritised for this period
Risks
Three products account for 62% of blocked revenueR4.2m
Eight key accounts with orders >30 days old8 accts
Critical replenishment date unconfirmedR0.7m
Demand exceeds forecast for Cardiaxol+18%
Opportunities
R2.1m ready for partial fulfilment+R2.1m
Redistribution reduces one major shortage+R0.42m
Prioritised allocation protects top accounts12 accts
Alternative stock resolves one delayed order+R0.28m
Detailed backorders
Order-level view — click a row to inspect
DateOrderAccountWholesalerProductOpenReadyAlloc.ValueAgeExpectedStatusSeverityOwnerAction
2026-06-12CO-9821MediRite SandtonWholesaler BCardiaxol 20mg1,400400200R0.42m18d05 JulOpencriticalSupplyExpedite
2026-06-08CO-9754Netcare PinelandsWholesaler ARespireze Inhaler900600R0.31m22dTodayReadycriticalCustomer SvcPartial fulfil
2026-06-04CO-9711Life Hospital UmhlangaNational Distribution GroupCardiaxol 40mg620R0.28m26d12 JulOpenwarningSupplyConfirm ETA
2026-06-19CO-9892Dis-Chem MenlynWholesaler BPulmavent DPI480120R0.22m11d08 JulOpenwarningSupplyExpedite
2026-06-02CO-9690Regional Hospital ZRegional Health SupplyCardiaxol 20mg380380R0.18m28dTodayReadycriticalCustomer SvcShip today
2026-06-21CO-9908Clicks RondeboschWholesaler CGastraven 20mg240240R0.11m9dTodayReadywarningCustomer SvcShip today
2026-05-30CO-9612Pharmacy Group QWholesaler ARespireze Inhaler320320R0.14m34d10 JulAllocatedcriticalSupplyPrioritise
2026-06-16CO-9853MediRite SandtonWholesaler BCardiaxol 40mg280R0.13m14d14 JulOpenwarningSupplyConfirm ETA